Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›FDA Molecular Modeling Simulation Platform or comparable

U.S. Department Of Health And Human Services·Maryland

FDA Molecular Modeling Simulation Platform or comparable

Closes 7/1/2026$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The FDA's Office of Product Quality and Research (OPQR) is seeking a molecular modeling simulation platform or comparable to support ongoing research. The platform should provide a comprehensive workflow, data management, and storage management, as well as computing resource management capability. The selected platform will be deployed on FDA's High-performance workstation with a Linux-based system. The vendor should have a proven track record of solving pharmaceutical and regulatory science challenges involving molecular dynamics and simulation. The platform should include features such as machine learning-based predictive modeling, molecular visualization, and chemical informatics. The vendor will be responsible for delivery, installation, on-site training, and technical support. Some key features of the platform include: * High-performance molecular dynamics simulations * Machine learning-based predictive modeling * Molecular visualization and chemical informatics * Conformational sampling * Scaffold replacement for novel molecule design * pKa and protonation state prediction tool * 3D-QSAR modeling * Ligand-receptor docking * Molecular mechanics simulations * Predicts drug permeability across membranes and interfaces * Protein structure prediction and refinement * Quantum mechanics and Molecular mechanics simulations for reactions of proteins and ligands * Binding site identification for proteins * Design, characterization, and optimization of drug formulations and delivery systems at the molecular level * Biologics modeling (e.g., antibodies)

Attached files

Contact

Raja J. Seshadri(Contract Specialist)

[email protected]

(661) 492-6197

Key dates

Opened
6/24/2026
Closes
7/1/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541511
Solicitation №
7571TEFDAMMSP

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is difficult to estimate, as the document does not provide a specific budget or pricing information. However, based on the complexity of the molecular modeling simulation platform and the scope of work, it is likely that the budget will be in the range of $500,000 to $2 million. This estimate takes into account the cost of software development, licensing, and technical support, as well as the potential for annual renewals of the subscription contract. Factors that may influence the likely payment range include the vendor's experience and reputation, the level of customization required, and the FDA's budget for research and development.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 73%

Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 11/20/2023

U.S. Food and Drug Administration·United States of America

69% match

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

67% match

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

66% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Health And Human Services·United States of America

66% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Food and Drug Administration·United States of America

65% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

65% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. National Institutes of Health·United States of America

64% match

RNomics Molecular Standards

Closes 2/14/2027Opened 8/5/2026

U.S. Department Of Energy·New Mexico

64% match

Simulator Collection for Atomic to Continuum Scales (SCACS)

Closes 2/15/2027Opened 8/18/2026

U.S. National Institutes of Health·United States of America

64% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

63% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. National Institutes of Health·United States of America

63% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. Department Of Health And Human Services·United States of America

63% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. Department Of Energy·Ohio

63% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. Department Of Energy·Ohio

63% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. Department Of Defense·Virginia

63% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 10/8/2026

U.S. National Science Foundation·United States of America

63% match

MPS Chemistry Research Programs (MPS Chem)

Closes 10/7/2076Opened 8/17/2026

U.S. Department Of Defense·Virginia

63% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 9/25/2026

U.S. Food and Drug Administration·United States of America

63% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. Food and Drug Administration·United States of America

62% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Defense·Maryland

62% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026

Department of Buildings and General Services VT·Vermont

62% match

State of Vermont Cloud Hosted Cannabis Laboratory Information System (LIMS) Bidder Response Form

Closes 11/6/2026Opened 10/16/2026

U.S. Department Of Health And Human Services·Georgia

62% match

NOTICE of Intent to SOLE SOURCE - DS Government Solutions

Closes 7/20/2027Opened 6/25/2026

U.S. National Institutes of Health·United States of America

62% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. Food and Drug Administration·United States of America

62% match

Laboratory Flexible Funding Model (LFFM)

Closes 1/11/2028Opened 2/6/2025